Robust Immunohistochemical Detection of α-Synuclein, Tau, and β-amyloid in Human Brain Tissue Archived for up to 78 Years

This study demonstrates that human brain tissue archived for up to 78 years, whether as paraffin-embedded blocks or in long-term fixative, remains suitable for robust immunohistochemical detection of key Alzheimer's and Lewy Body Disease pathologies, including α-synuclein, tau, and β-amyloid.

The Gist

Imagine you have a library of old, dusty books that contain the secrets to understanding how the human brain ages and gets sick. Some of these books were written as far back as the 1940s. For decades, scientists have wondered: Are these old books still readable? Or has the ink faded, the pages crumbled, and the stories lost forever?

This paper is essentially a "quality control check" on a massive collection of human brain tissue from Denmark, some of which has been sitting in jars or wrapped in wax for up to 78 years.

Here is the story of what they found, explained simply:

The Problem: The "Over-Fixing" Dilemma

When doctors examine a brain after someone passes away, they usually preserve it in a chemical bath called formalin (like a pickling solution) to stop it from rotting. Then, they often turn it into a hard block of wax (paraffin) to slice it thin for viewing under a microscope.

The problem is that formalin is a bit like a strong glue. If you leave tissue in it for too long, or if the tissue sits in a jar for 70 years, that "glue" can get so sticky that it hides the very things scientists are trying to see. It's like trying to read a letter that has been sealed inside a thick, hardened block of amber.

Scientists worried that for these ultra-old brains, the "glue" had become so strong that modern tests (called Immunohistochemistry, or IHC) couldn't find the disease markers anymore. They were afraid the "ink" of the disease had faded away.

The Experiment: The "Time-Travel" Test

The researchers took 41 brains from the Danish Brain Collection. These brains came from patients who died between 1946 and 1980.

• The "Gold Standard": They had the original wax blocks made back in the 1940s–80s.
• The "New" Sample: They took fresh slices of tissue from the same brains that had been sitting in liquid jars for decades, made new wax blocks, and tested them.

They looked for the three "villains" of brain disease:

1. Alpha-synuclein: The culprit in Parkinson's and Lewy Body Disease (think of it as sticky clumps of protein).
2. Tau: The culprit in Alzheimer's (think of it as tangled ropes inside brain cells).
3. Amyloid-beta: The other major Alzheimer's villain (think of it as hard, rocky plaques).

The Results: The Old Books Are Still Readable!

The big question was: Could they still see the disease in the 78-year-old samples?

The answer is a resounding YES.

• The "Glue" Didn't Win: Even though the tissue was incredibly old, the scientists found that with the right "key" (a specific chemical treatment called antigen retrieval and the right antibodies), they could unlock the hidden proteins.
• Parkinson's (Alpha-synuclein): The sticky clumps were clearly visible in the old samples. They looked almost as good as the fresh ones.
• Alzheimer's (Amyloid-beta): The rocky plaques were just as easy to spot in the 78-year-old tissue as in the newer tissue.
• The "Tangled Ropes" (Tau): This was the only tricky part. In some of the very oldest samples (from the 1950s), the tangled ropes were a little harder to see than in the newer samples. However, they were still there, and the difference wasn't huge.

The Analogy: The "Vintage Wine" Effect

Think of these brain tissues like vintage wine.

• If you open a bottle of wine that is 78 years old, you might expect it to be vinegar or empty.
• But this study shows that if you have the right glass and the right way to pour it (the right lab techniques), the wine is still rich, complex, and full of flavor.
• In fact, the researchers found that after a certain point (maybe the first 10–20 years of "aging"), the quality stops getting worse. It hits a "plateau." The 1940s samples were just as good as the 1970s samples. The "aging" didn't keep getting worse and worse; it just stabilized.

Why Does This Matter?

This is a huge victory for medical research.

1. Treasure Trove: There are thousands of brains in storage from the mid-20th century. Before this study, scientists might have been afraid to touch them, thinking the data was ruined. Now, we know these are gold mines of information.
2. New Insights: These brains come from people who lived before modern pollution, before modern drugs, and before modern diets. By studying them, we can learn how the brain worked in a "cleaner" era, helping us understand what has changed in our modern world.
3. No Need to Wait: We don't have to wait 50 years for new brain banks to grow. We can start learning from the ones we already have right now.

The Bottom Line

The paper concludes that human brain tissue is incredibly resilient. Even if it has been sitting in a jar or a wax block for nearly 80 years, we can still use it to diagnose and study diseases like Alzheimer's and Parkinson's. The "ink" hasn't faded; we just needed to find the right magnifying glass to read it.

Technical Summary

1. Problem Statement

Neurodegenerative diseases like Alzheimer's Disease (AD) and Lewy Body Disease (LBD, including Parkinson's Disease) are primarily diagnosed and researched through the immunohistochemical (IHC) analysis of protein aggregates (α-synuclein, hyperphosphorylated tau, and amyloid-β) in brain tissue.

• The Challenge: Many valuable brain collections (e.g., the Danish Brain Collection) contain tissue collected between the 1940s and 1980s. This tissue has been preserved either as formalin-fixed paraffin-embedded (FFPE) blocks or stored in liquid fixative for decades (up to 78 years).
• The Concern: Prolonged fixation and long-term storage can lead to epitope masking, antigen degradation, and oxidation of formalin into formic acid, potentially rendering the tissue unsuitable for modern IHC techniques. There is a lack of systematic data on whether such "archival" tissue can still reliably detect the pathological hallmarks of AD and LBD.

2. Methodology

The study utilized a unique cohort from the Danish Brain Collection to compare original FFPE blocks against newly prepared blocks derived from the same long-term fixated tissue.

• Cohort: 41 autopsy cases collected between 1946 and 1980.
  • Timeframes: Cases were stratified by decade (1940s, 1950s, 1960s, 1970s).
  • Tissue Types: For each case, midbrain and hippocampus were available as both original paraffin blocks and tissue stored in fixative.
  • Fixation Duration: The "new" blocks were sampled from tissue that had been in fixative for 40–78 years.
• Regions Analyzed: Substantia nigra (SN), periaqueductal grey (PAG), hippocampus (CA1, CA2), entorhinal cortex (Ent Cx), and temporo-occipital cortex (TO Cx).
• Immunohistochemistry (IHC) Protocol:
  • Platform: Automated Ventana Benchmark Ultra.
  • Antibodies:
    • α-Synuclein: Clone 5G4 (selected for its known efficacy in archival tissue).
    • Hyperphosphorylated Tau: Clone AT8.
    • Amyloid-β: Clone 4G8.
  • Antigen Retrieval: Critical step involving heat treatment (95°C) followed by incubation in 98% Formic Acid (FA) to unmask epitopes.
• Assessment:
  • Semi-quantitative Scoring: Pathology was scored on a scale of 0–3 (0: absent; 1: occasional; 2: moderate; 3: severe) for specific structures (Lewy bodies, Lewy neurites, neurofibrillary tangles, neuropil threads, senile plaques, and astrocytic α-synuclein).
  • Comparison: Original blocks served as the "gold standard" against the newly prepared blocks.
  • Statistics: Non-parametric Wilcoxon rank-sum test was used to compare scores between original and new blocks.

3. Key Contributions

• First Systematic Evaluation of Extreme Age: This is the first study to systematically evaluate the viability of brain tissue archived for up to 78 years for the detection of AD and LBD protein aggregates.
• Validation of Long-Term Fixation: It demonstrates that tissue stored in liquid fixative for decades retains sufficient antigenicity for robust IHC detection when combined with optimized antigen retrieval (specifically formic acid).
• Antibody Selection Confirmation: The study validates the continued utility of specific antibody clones (5G4 for α-synuclein, AT8 for tau, 4G8 for Aβ) in extremely old tissue, confirming that 5G4 is particularly effective for detecting astrocytic α-synuclein in archival samples.
• Plateau Effect Hypothesis: The data suggests that antigenicity loss may reach a plateau after the first few years of fixation, meaning tissue fixed for 10 years vs. 70 years may not differ significantly in detectability if protocols are optimized.

4. Results

The study analyzed 162 paraffin blocks, performing 394 IHC stains across 944 regions.

• General Staining Quality: Good-to-excellent staining quality was achieved across all decades and both tissue types (original and new).
• α-Synuclein (Lewy Pathology):
  • Lewy Bodies (LBs) & Neurites (LNs): New blocks showed slightly lower semi-quantitative scores than original blocks, but no statistically significant differences were found in any region or decade.
  • Astrocytic α-Synuclein: Generally well-detected. A statistically significant reduction in new blocks was observed only in the substantia nigra of cases from the 1960s ($p < 0.05$).
• Tau Pathology:
  • Neurofibrillary Tangles (NFTs): Generally well-preserved. Significant differences were rare, appearing only in the CA2 region of the 1950s group and the temporo-occipital cortex of the 1950s group.
  • Neuropil Threads (NTs): Showed the most sensitivity to prolonged fixation. Significant reductions in new blocks were observed in the 1950s group across all regions (CA2, CA1, Ent Cx, TO Cx) and in specific regions of the 1960s and 1970s groups. This suggests NTs are more vulnerable to antigen loss than NFTs.
• Amyloid-β (Senile Plaques):
  • New blocks showed similar or slightly higher scores compared to original blocks.
  • No statistically significant differences were found across any region or decade.
  • Cerebral Amyloid Angiopathy (CAA) was detected in both block types where present.

5. Significance and Conclusion

• Scientific Resource Preservation: The study confirms that vast historical brain collections (dating back to the 1940s) are not obsolete. They remain a viable resource for contemporary research into the neuropathology of AD and LBD.
• Methodological Implication: The success of the study relies heavily on optimized antigen retrieval, specifically the use of formic acid pretreatment. Without this, antigenicity would likely be too low for detection.
• Clinical and Research Impact: Researchers can confidently utilize archival tissue to study disease progression, environmental factors, and historical cohorts, provided they use appropriate antibodies (like 5G4) and retrieval protocols.
• Limitations: The study noted that while overall detection is robust, specific structures like neuropil threads and astrocytic α-synuclein in certain decades showed slight degradation. Additionally, biological variation due to sampling location (original vs. new block) could not be fully ruled out.

Conclusion: Human brain tissue preserved as FFPE blocks or stored in fixative for up to 78 years remains suitable for immunohistochemical analysis. Adequate-to-good detection of aggregated α-synuclein, hyperphosphorylated tau, and amyloid-β is achievable, preserving the pathological hallmarks of Lewy Body Disease and Alzheimer's Disease for future study.